Health and Healthcare
The Worst May Not Be Over For MedCath (MDTH)
Published:
Last Updated:
MedCath Corp. (NASDAQ: MDTH) took a particularly brutal beating at the end of last week after posting disappointing results. The stock fell nearly 50% on Friday to $7.55, a 52-week low against a period high of $27. We covered this stock this weekend in our weekly "Under $10 Stocks" newsletter that went out Sunday night, and a brief synopsis has been provided below:
The firm which provides products for diagnosis and treatment ofcardiovascular disease posted a revenue increase of 4.0% to $150.9million in the fourth quarter of fiscal 2008 from $145.1 million in thefourth quarter of fiscal 2007. Income from continuing operations was$0.4 million, or $0.02 per diluted share, in the fourth quarter offiscal 2008 compared to $2.5 million, or $0.11 per diluted share, inthe fourth quarter of fiscal 2007.
Aside from weak results, the market was upset by a $160 million loan facilitywhich the company took on. It has as security a lien on the assets ofMedCath and its wholly owned subsidiaries. MDTH also said it wouldsuspend guidance due to difficult conditions in the overall medicalindustry. MedCath has long-term debt of $116 million, which is inexcess of its cash position of $94 million.
Spending on high-end medical procedures and equipment is bound to be hit by the recession. MDTH has a rough road ahead.
From the $7.71 close Friday, we expect the shares to go lower.
Douglas A. McIntyre
November 17, 2008
Want to Retire Early? Start Here (Sponsor)
Want retirement to come a few years earlier than you’d planned? Or are you ready to retire now, but want an extra set of eyes on your finances?
Now you can speak with up to 3 financial experts in your area for FREE. By simply clicking here you can begin to match with financial professionals who can help you build your plan to retire early. And the best part? The first conversation with them is free.
Click here to match with up to 3 financial pros who would be excited to help you make financial decisions.
Have questions about retirement or personal finance? Email us at [email protected]!
By emailing your questions to 24/7 Wall St., you agree to have them published anonymously on a673b.bigscoots-temp.com.
By submitting your story, you understand and agree that we may use your story, or versions of it, in all media and platforms, including via third parties.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.
Latest from 24/7
